198 related articles for article (PubMed ID: 2447941)
21. A new direct radioimmunoassay of rat urinary kininogen.
Oza NB
Biochem Pharmacol; 1988 May; 37(10):1965-9. PubMed ID: 3377804
[TBL] [Abstract][Full Text] [Related]
22. Kinin release from kininogens by calpains.
Higashiyama S; Ishiguro H; Ohkubo I; Fujimoto S; Matsuda T; Sasaki M
Life Sci; 1986 Nov; 39(18):1639-44. PubMed ID: 3022089
[TBL] [Abstract][Full Text] [Related]
23. Functionally active high molecular weight-kininogen was found in the liver, but not in the plasma of brown Norway Katholiek rat.
Hayashi I; Maruhashi J; Oh-ishi S
Thromb Res; 1989 Oct; 56(2):179-89. PubMed ID: 2617467
[TBL] [Abstract][Full Text] [Related]
24. Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein.
Mori K; Sakamoto W; Nagasawa S
J Biochem; 1981 Aug; 90(2):503-9. PubMed ID: 6913579
[TBL] [Abstract][Full Text] [Related]
25. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
Shimada T; Kato H; Maeda H; Iwanaga S
J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613
[TBL] [Abstract][Full Text] [Related]
26. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
Thompson RE; Mandle R; Kaplan AP
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
[TBL] [Abstract][Full Text] [Related]
27. [DNA analysis for the kininogen gene of patients with kininogen deficiency in Japan].
Hayashi H; Ishimaru F; Fujita T; Tsurumi N; Tsuda T; Kimura I
Rinsho Ketsueki; 1989 Oct; 30(10):1694-701. PubMed ID: 2593235
[TBL] [Abstract][Full Text] [Related]
28. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
Bock PE; Shore JD; Tans G; Griffin JH
J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
[TBL] [Abstract][Full Text] [Related]
29. Purification and characterization of alpha 1-thiol proteinase inhibitor and its identity with kinin- and fragment 1.2-free high molecular weight kininogen.
Ohkubo I; Namikawa C; Higashiyama S; Sasaki M; Minowa O; Mizuno Y; Shiokawa H
Int J Biochem; 1988; 20(3):243-58. PubMed ID: 3356290
[TBL] [Abstract][Full Text] [Related]
30. Tissue distribution and kininogen gene expression after acute-phase inflammation.
Chao J; Swain C; Chao S; Xiong W; Chao L
Biochim Biophys Acta; 1988 Mar; 964(3):329-39. PubMed ID: 3126819
[TBL] [Abstract][Full Text] [Related]
31. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
[TBL] [Abstract][Full Text] [Related]
32. Purification and immunochemical properties of human low molecular weight kininogen.
Sakamoto W; Nishikaze O
J Biochem; 1979 Nov; 86(5):1549-57. PubMed ID: 118172
[TBL] [Abstract][Full Text] [Related]
33. Some molecular and functional changes in high molecular weight kininogen induced by plasmin and trypsin.
Kleniewski J; Donaldson VH; Wagner CJ
Thromb Res; 1982 Mar; 25(5):387-99. PubMed ID: 6176044
[TBL] [Abstract][Full Text] [Related]
34. Molecular biology of the angiotensinogen and kininogen genes.
Kitamura N; Ohkubo H; Nakanishi S
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S49-53. PubMed ID: 2485063
[TBL] [Abstract][Full Text] [Related]
35. Purification and characterization of rat low molecular weight kininogen.
Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O; Handa H
J Biochem; 1984 Jul; 96(1):81-8. PubMed ID: 6238024
[TBL] [Abstract][Full Text] [Related]
36. Limited proteolysis of HMW kininogen by plasma kallikrein in man--evidence for a processing mechanism different from the bovine system.
Müller-Esterl W; Hock H; Rauth G; Kellermann J; Lottspeich F; Henschen A
Adv Exp Med Biol; 1986; 198 Pt A():97-103. PubMed ID: 3643720
[TBL] [Abstract][Full Text] [Related]
37. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
[TBL] [Abstract][Full Text] [Related]
38. Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.
Kleniewski J; Donaldson VH
J Lab Clin Med; 1987 Apr; 109(4):469-79. PubMed ID: 2950194
[TBL] [Abstract][Full Text] [Related]
39. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.
Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W
J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
Sugi T; Mclntyre JA
Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
